• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥密克戎变异株感染及其相关免疫情况。

Omicron variant infection and the associated immunological scenario.

机构信息

Department of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore, Tamil Nadu 632014, India.

Department of Biosciences, School of Bio-Sciences and Technology, Vellore Institute of Technology (VIT), Vellore, Tamil Nadu 632014, India.

出版信息

Immunobiology. 2022 May;227(3):152222. doi: 10.1016/j.imbio.2022.152222. Epub 2022 May 4.

DOI:10.1016/j.imbio.2022.152222
PMID:35533536
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9065598/
Abstract

The million-dollar question that has been the talk of the day is how effective the COVID 19 vaccines are against the Omicron variant. Still, there is no clear-cut answer to this question but several studies have concluded that this Variant of Concern (VOC) successfully weakens the neutralizing capability of the antibodies acquired from the COVID 19 vaccines and prior infections, which indicates that Omicron can easily bypass an individual's humoral immune response. However, the most significant confusion revolves around cell-mediated immunity tackling the Omicron variant. This paper aims to provide a clear idea about the status of the body's immune surveillance concerning the infection caused by the Omicron variant by producing the effectivity of the humoral and cell-mediated immunity in handling the same. This work also provides complete detail of the various characteristics of the Omicron variant and how it may be a blessing in disguise. The effectiveness of the current vaccines, the transmissibility rate of the variant compared to the other variants, and the importance of administering a booster dose to prevent the spread of this variant are also discussed. Finally, this work aims to bridge the gap between the past and the current status of the Omicron infection and sheds light on the hypothetical idea that herd immunity developed from the SARS-COV2 infection may help tackle other dangerous variants.

摘要

目前人们热议的焦点问题是,新冠疫苗对奥密克戎变异株的有效性如何。但对于这个问题,目前尚无明确答案。不过,有几项研究的结论表明,这种关注的变异株(VOC)成功削弱了新冠疫苗和既往感染产生的抗体的中和能力,这表明奥密克戎可以轻易绕过个体的体液免疫反应。然而,最大的困惑集中在针对奥密克戎变异株的细胞介导免疫上。本文旨在通过研究体液和细胞介导免疫对奥密克戎变异株感染的作用效果,提供关于机体免疫监测对奥密克戎变异株感染状况的清晰认识。本文还详细介绍了奥密克戎变异株的各种特征,以及它可能是因祸得福的原因。此外,还讨论了目前疫苗的有效性、该变异株与其他变异株相比的传染性以及接种加强针以防止该变异株传播的重要性。最后,本文旨在弥合奥密克戎感染过去和现状之间的差距,并提出一个假设性的观点,即从 SARS-COV2 感染中产生的群体免疫可能有助于应对其他危险的变异株。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ae3/9065598/74de32754a67/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ae3/9065598/b253824415cb/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ae3/9065598/74de32754a67/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ae3/9065598/b253824415cb/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ae3/9065598/74de32754a67/gr2_lrg.jpg

相似文献

1
Omicron variant infection and the associated immunological scenario.奥密克戎变异株感染及其相关免疫情况。
Immunobiology. 2022 May;227(3):152222. doi: 10.1016/j.imbio.2022.152222. Epub 2022 May 4.
2
Omicron variant of SARS-CoV-2 infection elicits cross-protective immunity in people who received boosters or infected with variant strains.奥密克戎变异株 SARS-CoV-2 感染可引起接受加强针或感染变异株人群的交叉保护免疫。
Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221133001. doi: 10.1177/03946320221133001.
3
A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.一种糖基化 RBD 蛋白诱导针对奥密克戎和其他变体的增强型中和抗体,提高对 SARS-CoV-2 感染的保护作用。
J Virol. 2022 Sep 14;96(17):e0011822. doi: 10.1128/jvi.00118-22. Epub 2022 Aug 16.
4
Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 Vaccine.评估 2 至 3 剂 BNT162b2 mRNA COVID-19 疫苗后针对 SARS-CoV-2 变异株的中和抗体反应。
JAMA Netw Open. 2022 May 2;5(5):e2210780. doi: 10.1001/jamanetworkopen.2022.10780.
5
Delta Infection After Vaccination Elicits Potent Neutralizing Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron.接种疫苗后的德尔塔变异株感染可引发针对严重急性呼吸综合征冠状病毒 2 型奥密克戎的强烈中和免疫。
J Infect Dis. 2022 Nov 1;226(9):1551-1555. doi: 10.1093/infdis/jiac149.
6
SARS-CoV-2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID-19 vaccine: Looking for correlates of protection.Omicron BA.1 变异株突破感染同源第三剂 Comirnaty® COVID-19 疫苗后的养老院居民:寻找保护相关因素。
J Med Virol. 2022 Sep;94(9):4216-4223. doi: 10.1002/jmv.27867. Epub 2022 May 25.
7
Effectiveness of the third dose of BNT162b2 vaccine on neutralizing Omicron variant in the Japanese population.第三剂 BNT162b2 疫苗对日本人群中奥密克戎变异株的中和效果。
J Infect Chemother. 2022 Sep;28(9):1273-1278. doi: 10.1016/j.jiac.2022.05.009. Epub 2022 Jun 10.
8
Durability of Immune Response After COVID-19 Booster Vaccination and Association With COVID-19 Omicron Infection.COVID-19 加强针接种后免疫反应的持久性及其与 COVID-19 奥密克戎感染的关联。
JAMA Netw Open. 2022 Sep 1;5(9):e2231778. doi: 10.1001/jamanetworkopen.2022.31778.
9
Vaccination After SARS-CoV-2 Infection Increased Antibody Avidity Against the Omicron Variant Compared to Vaccination Alone.与单独接种疫苗相比,感染 SARS-CoV-2 后接种疫苗可提高针对奥密克戎变异株的抗体亲合力。
J Infect Dis. 2022 Nov 11;226(10):1712-1716. doi: 10.1093/infdis/jiac247.
10
mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant.mRNA 加强免疫可引发针对 SARS-CoV-2 奥密克戎变异株的强效中和血清活性。
Nat Med. 2022 Mar;28(3):477-480. doi: 10.1038/s41591-021-01676-0. Epub 2022 Jan 19.

引用本文的文献

1
Genomic epidemiology and evolutionary dynamics of the Omicron variant of SARS-CoV-2 during the fifth wave of COVID-19 in Pakistan.巴基斯坦第五波 COVID-19 期间 SARS-CoV-2 的奥密克戎变体的基因组流行病学和进化动态。
Front Cell Infect Microbiol. 2024 Oct 22;14:1484637. doi: 10.3389/fcimb.2024.1484637. eCollection 2024.
2
Exploring the Syndecan-Mediated Cellular Internalization of the SARS-CoV-2 Omicron Variant.探索 SARS-CoV-2 奥密克戎变异株通过 syndecan 介导的细胞内化作用。
Int J Mol Sci. 2023 Sep 15;24(18):14140. doi: 10.3390/ijms241814140.
3
Recipient-Reported Reactogenicity of Different SARS-CoV-2 Vaccination Regimens among Healthcare Professionals and Police Staff in Germany.

本文引用的文献

1
Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles.奥密克戎突变增强了 SARS-CoV-2 病毒样颗粒的感染力,并降低了抗体的中和作用。
Proc Natl Acad Sci U S A. 2022 Aug 2;119(31):e2200592119. doi: 10.1073/pnas.2200592119. Epub 2022 Jul 19.
2
COVID-19 and retinal degenerative diseases: Promising link "Kaempferol".COVID-19 和视网膜退行性疾病:有希望的联系“山奈酚”。
Curr Opin Pharmacol. 2022 Jun;64:102231. doi: 10.1016/j.coph.2022.102231. Epub 2022 Apr 14.
3
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design.
德国医护人员和警察中不同SARS-CoV-2疫苗接种方案的受种者报告的反应原性
Vaccines (Basel). 2023 Jun 25;11(7):1147. doi: 10.3390/vaccines11071147.
4
Recent trends in carbon nanotube (CNT)-based biosensors for the fast and sensitive detection of human viruses: a critical review.基于碳纳米管(CNT)的生物传感器用于快速灵敏检测人类病毒的最新趋势:综述。
Nanoscale Adv. 2022 Nov 9;5(4):992-1010. doi: 10.1039/d2na00236a. eCollection 2023 Feb 14.
5
A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies.关于 SARS-CoV-2 奥密克戎的详细概述:其亚变体、突变和病理生理学、临床特征、免疫状况、免疫逃逸以及治疗方法。
Viruses. 2023 Jan 5;15(1):167. doi: 10.3390/v15010167.
6
Choosing a cellular model to study SARS-CoV-2.选择用于研究 SARS-CoV-2 的细胞模型。
Front Cell Infect Microbiol. 2022 Oct 21;12:1003608. doi: 10.3389/fcimb.2022.1003608. eCollection 2022.
7
Cheminformatics-Based Discovery of Potential Chemical Probe Inhibitors of Omicron Spike Protein.基于 cheminformatics 的奥密克戎刺突蛋白潜在化学探针抑制剂的发现。
Int J Mol Sci. 2022 Sep 7;23(18):10315. doi: 10.3390/ijms231810315.
8
Understanding and combating COVID-19 using the biology and chemistry of SARS-CoV-2.利用 SARS-CoV-2 的生物学和化学特性了解和抗击 COVID-19。
Bioprocess Biosyst Eng. 2022 Nov;45(11):1753-1769. doi: 10.1007/s00449-022-02788-8. Epub 2022 Sep 20.
9
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?奥密克戎变异株(B.1.1.529)及其亚谱系:在 SARS-CoV-2 重组变异株出现之际,我们目前了解多少?
Biomed Pharmacother. 2022 Oct;154:113522. doi: 10.1016/j.biopha.2022.113522. Epub 2022 Aug 15.
10
Structural and Phylogenetic Analysis of SARS-CoV-2 Spike Glycoprotein from the Most Widespread Variants.对最广泛传播的新冠病毒变异株刺突糖蛋白的结构和系统发育分析
Life (Basel). 2022 Aug 16;12(8):1245. doi: 10.3390/life12081245.
苏格兰关注的奥密克戎变异株的严重程度和疫苗加强针预防有症状疾病的效果(EAVE II):一项具有巢式病例对照研究设计的全国队列研究。
Lancet Infect Dis. 2022 Jul;22(7):959-966. doi: 10.1016/S1473-3099(22)00141-4. Epub 2022 Apr 22.
4
Are new Omicron subvariants a threat? Here's how scientists are keeping watch.新型奥密克戎亚变体构成威胁吗?以下是科学家的监测方式。
Nature. 2022 Apr;604(7907):605-606. doi: 10.1038/d41586-022-01069-4.
5
Recent advances in green technology and Industrial Revolution 4.0 for a sustainable future.绿色技术和工业革命 4.0 的最新进展,实现可持续的未来。
Environ Sci Pollut Res Int. 2023 Dec;30(60):124488-124519. doi: 10.1007/s11356-022-20024-4. Epub 2022 Apr 9.
6
Advances in the Omicron variant development.奥密克戎变异株的研究进展。
J Intern Med. 2022 Jul;292(1):81-90. doi: 10.1111/joim.13478. Epub 2022 Mar 22.
7
Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays.使用中和及特异性酶联免疫吸附测定法检测疫苗抗体对奥密克戎和新冠病毒变体的中和作用。
J Infect. 2022 Jun;84(6):834-872. doi: 10.1016/j.jinf.2022.02.031. Epub 2022 Mar 10.
8
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.Covid-19 疫苗对奥密克戎(B.1.1.529)变异株的有效性。
N Engl J Med. 2022 Apr 21;386(16):1532-1546. doi: 10.1056/NEJMoa2119451. Epub 2022 Mar 2.
9
Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody.奥密克戎刺突三聚体与 ACE2 和抗奥密克戎抗体复合物的结构。
Science. 2022 Mar 4;375(6584):1048-1053. doi: 10.1126/science.abn8863. Epub 2022 Feb 8.
10
Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron.疫苗引发针对 SARS-CoV-2 奥密克戎的高度保守的细胞免疫。
Nature. 2022 Mar;603(7901):493-496. doi: 10.1038/s41586-022-04465-y. Epub 2022 Jan 31.